Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.50    1.00 (1.55%)
Bid:
65.00
Ask:
65.90
Spread: 0.90 (1.385%)
Market Cap: £578.65m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director/PDMR Shareholding

27 Sep 2021 12:40

RNS Number : 0863N
IP Group PLC
27 September 2021
 

FOR RELEASE ON

27 September 2021

 

IP Group plc - Director/PDMR Shareholding

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces that, further to the announcements dated 05 August 2021 and 19 August 2021 in connection with the Interim Scrip Dividend, a combined total of 1,645 new Ordinary Shares in aggregate have been allotted to one of the Group's executive directors and two of its PDMRs, following their respective elections to take up the Interim Scrip Dividend in relation to some or all of their current shareholdings, as further detailed below

 

Shares in issue

The Group currently has 1,063,033,287 Shares in issue. The Group does not hold any shares in Treasury.

 

The following information is being disclosed pursuant to the requirements of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

Scrip Election

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Greg Smith 

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Election of Scrip Dividend

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Name(s)

Price(s)

Volume(s)

Greg Smith

 131.4p

680

 

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

680

131.4p

£893.52

f)

Date of the transaction

27 September 2021

g)

Place of the transaction

London Stock Exchange, Main Market

 

 

1

 

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Angela Leach 

2

Reason for the notification

a)

Position/status

PDMR General Counsel & Company Secretary

b)

Initial notification /Amendment

Initial Notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Election of Scrip Dividend

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Name(s)

Price(s)

Volume(s)

Angela Leach

 131.4p

 928

 

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

928

131.4p

£1,219.40

f)

Date of the transaction

27 September 2021

g)

Place of the transaction

London Stock Exchange, Main Market

 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

DR Lisa Patel 

2

Reason for the notification

a)

Position/status

PDMR Partner, Life Sciences

b)

Initial notification /Amendment

Initial Notification 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Election of Scrip Dividend

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Name(s)

Price(s)

Volume(s)

Dr. Lisa Patel

 131.4p

 37

 

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

37

131.4p

£48.62

f)

Date of the transaction

27 September 2021

g)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

 

Andrew Wilson

+44 (0) 7810 636995

David Gaffney

+44 (0) 7854 609998

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPURWBUPGGGM
Date   Source Headline
3rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jul 202012:02 pmRNSPrice Monitoring Extension
24th Jun 20202:39 pmRNSHolding(s) in Company
24th Jun 20208:10 amRNSHolding(s) in Company
23rd Jun 202011:37 amRNSLTIP & DBSP awards; Director/PDMR shareholding
18th Jun 20202:05 pmRNSResult of AGM
18th Jun 20207:00 amRNSAGM Statement
9th Jun 20205:47 pmRNSAGM update
5th Jun 20206:28 pmRNSHolding(s) in Company
26th May 202010:05 amRNSInivata receives $25m investment from NeoGenomics
26th May 20207:00 amRNSOxford Nanopore announces £48.4m of new funding
22nd May 20207:00 amRNSOxford Nanopore in development of covid19 test
21st May 20207:00 amRNSIP Group sells 12.25m shares in Ceres Power
21st May 20207:00 amRNSResult of secondary placing in Ceres Power
20th May 20204:48 pmRNSProposed secondary placing in Ceres Power Holdings
19th May 202012:02 pmRNSPrice Monitoring Extension
15th May 20204:36 pmRNSPrice Monitoring Extension
13th May 202012:08 pmRNSSecond Price Monitoring Extn
13th May 202012:03 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSFeaturespace completes £30m funding round
12th May 202012:02 pmRNSPrice Monitoring Extension
7th May 202012:02 pmRNSPrice Monitoring Extension
29th Apr 20204:57 pmRNSHolding(s) in Company
24th Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20203:45 pmRNSNotice of AGM
8th Apr 20205:04 pmRNSHolding(s) in Company
6th Apr 20205:45 pmRNSHolding(s) in Company
30th Mar 20202:12 pmRNSIssue of Equity
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20209:00 amRNSHolding(s) in Company
11th Mar 20207:01 amRNSDirectorate Change
11th Mar 20207:00 amRNSFinal Results
23rd Jan 20202:46 pmRNSHolding(s) in Company
22nd Jan 20205:12 pmRNSHolding(s) in Company
22nd Jan 202012:46 pmRNSBosch to increase holding in Ceres Power to c18%
17th Jan 20204:07 pmRNSHolding(s) in Company
3rd Jan 20202:18 pmRNSForm 8.3 - Hvivo plc
2nd Jan 20207:00 amRNSOxford Nanopore completes £109.5m financing
19th Dec 20197:00 amRNSDirector Declaration
17th Dec 20194:50 pmRNSShare Capital Reduction Effective
12th Dec 201910:52 amRNSHolding(s) in Company
10th Dec 20191:12 pmRNSOxford Nanopore selected as sequencing partner
4th Dec 20194:10 pmRNSHolding(s) in Company
28th Nov 20194:10 pmRNSHolding(s) in Company
26th Nov 201911:24 amRNSHolding(s) in Company
25th Nov 20191:59 pmRNSResult of General Meeting
22nd Nov 20195:51 pmRNSHolding(s) in Company
11th Nov 20197:00 amRNSHolding(s) in Company
8th Nov 201912:02 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.